Correlation Between Satsuma Pharmaceuticals and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Satsuma Pharmaceuticals and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Satsuma Pharmaceuticals and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Satsuma Pharmaceuticals and Protara Therapeutics, you can compare the effects of market volatilities on Satsuma Pharmaceuticals and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Satsuma Pharmaceuticals with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Satsuma Pharmaceuticals and Protara Therapeutics.
Diversification Opportunities for Satsuma Pharmaceuticals and Protara Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Satsuma and Protara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Satsuma Pharmaceuticals and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Satsuma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Satsuma Pharmaceuticals are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Satsuma Pharmaceuticals i.e., Satsuma Pharmaceuticals and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Satsuma Pharmaceuticals and Protara Therapeutics
Given the investment horizon of 90 days Satsuma Pharmaceuticals is expected to generate 1.33 times more return on investment than Protara Therapeutics. However, Satsuma Pharmaceuticals is 1.33 times more volatile than Protara Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Protara Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 86.00 in Satsuma Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 24.00 from holding Satsuma Pharmaceuticals or generate 27.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 16.4% |
| Values | Daily Returns |
Satsuma Pharmaceuticals vs. Protara Therapeutics
Performance |
| Timeline |
| Satsuma Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Protara Therapeutics |
Satsuma Pharmaceuticals and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Satsuma Pharmaceuticals and Protara Therapeutics
The main advantage of trading using opposite Satsuma Pharmaceuticals and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Satsuma Pharmaceuticals position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| Satsuma Pharmaceuticals vs. Erasca Inc | Satsuma Pharmaceuticals vs. Forte Biosciences | Satsuma Pharmaceuticals vs. SAB Biotherapeutics | Satsuma Pharmaceuticals vs. Senti Biosciences |
| Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology | Protara Therapeutics vs. Xilio Development |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |